Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Applied Research in Mental Retardation|January 1, 1986
Neonatal network: a model for interagency service coordination for very-low-birth-weight infants and their familiesC J SemmlerThe American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association|June 1, 1991
Ethical dilemmas in driver reeducationC A Cook, C J SemmlerInternational Journal of Immunopharmacology|April 1, 1993
The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cellsJ Semmler, H Wachtel, S EndresJournal of Pharmacological and Toxicological Methods|September 1, 1995
Radioimmunoassays for cyclic AMP cross-react with phosphodiesterase inhibitors and buffer componentsB Sinha, J Semmler, E Haen, et al.European Journal of Immunology|January 1, 1995
Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoidsB Sinha, J Semmler, T Eisenhut, et al.Zentralblatt Fur Neurochirurgie|January 1, 1988
[Injuries of the basilar artery]H E Vitzthum, D Mohnicke, J Semmler, et al.Klinische Padiatrie|November 29, 2014
Re-induction with L-DNR/FLAG improves response after AML relapse, but not long-term survivalU Creutzig, J Semmler, G L Kaspers, et al.Plastic and Reconstructive Surgery|March 5, 2008
Extensor tendon injuries: acute management and secondary reconstructionKevin R Hanz, Michel Saint-Cyr, Maynard J Semmler, et al.Science (New York, N.Y.)|April 15, 1973
1 -Hydroxy derivative of vitamin D 3 : a highly potent analog of 1 ,25-dihydroxyvitamin D 3M F Holick, E J Semmler, H K Schnoes, et al.Immunopharmacology|November 1, 1993
Prostacyclin analogs suppress the synthesis of tumor necrosis factor-alpha in LPS-stimulated human peripheral blood mononuclear cellsT Eisenhut, B Sinha, E Gröttrup-Wolfers, et al.Pageof 3